Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints Rafia Bhore, PhD Statistical Scientist, Novartis Email: [email protected].
Evaluating Change in Hazard in Clinical Trials With Time-to-Event Safety Endpoints